Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-21-008086

Chief Financial Officer sold 2,500 shares at $60.00 ($150,000)

  • Chief Financial Officer acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBERTSON MICHELLE · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-09 Exercise or conversion : show line 1 in the form +2,500 $30.65 $76,625 31,235 D
2021-08-09 Sale : show line 2 in the form −2,500 $60.00 $150,000 28,735 D
Open-market sales · 2,500 sh · avg $60.00 · $150,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-09 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −2,500 115,000 D
Loading xslF345X03/edgar.xml…